Tower Research Capital (TRC)’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,603
Closed -$1.83K 6108
2024
Q1
$1.83K Sell
2,603
-3,062
-54% -$3.46K ﹤0.01% 5174
2023
Q4
$9.91K Buy
+5,665
New +$8.27K ﹤0.01% 4330
2023
Q1
Sell
-1,704
Closed -$3K 6464
2022
Q4
$3K Sell
1,704
-3,643
-68% -$9.69K ﹤0.01% 5268
2022
Q3
$21K Buy
5,347
+2,617
+96% +$16.1K ﹤0.01% 3916
2022
Q2
$15K Sell
2,730
-1,045
-28% -$8.56K ﹤0.01% 4106
2022
Q1
$55K Sell
3,775
-5,314
-58% -$71.1K ﹤0.01% 2663
2021
Q4
$143K Buy
9,089
+2,315
+34% +$55.6K ﹤0.01% 2001
2021
Q3
$217K Buy
6,774
+1,561
+30% +$54.8K 0.01% 1750
2021
Q2
$217K Buy
5,213
+3,496
+204% +$144K 0.01% 1857
2021
Q1
$87K Buy
1,717
+19
+1% +$994 ﹤0.01% 2696
2020
Q4
$55K Sell
1,698
-5,832
-77% -$82.7K ﹤0.01% 3033
2020
Q3
$90K Buy
7,530
+7,134
+1,802% +$82.7K ﹤0.01% 3228
2020
Q2
$5K Buy
396
+307
+345% +$4K ﹤0.01% 4306
2020
Q1
$1K Buy
+89
New +$1.09K ﹤0.01% 2878
2019
Q4
Sell
-200
Closed -$1K 4551
2019
Q3
$1K Sell
200
-81
-29% -$966 ﹤0.01% 3952
2019
Q2
$6K Hold
281
﹤0.01% 2887
2019
Q1
$6K Buy
281
+232
+473% +$4.76K ﹤0.01% 2987
2018
Q4
$1K Buy
+49
New +$995 ﹤0.01% 3695

Other funds holding DMTK

Tower Research Capital (TRC)'s DMTK Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 2,603 shares — an estimated $1.83K sold.

Tower Research Capital (TRC) first reported a position in DMTK in Q4 2018 and held it in 18 quarters. The position peaked at $217K in Q3 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,603 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $1.83K.
  • Tower Research Capital (TRC) first reported a position in DermTech, Inc. Common Stock in Q4 2018 and held it in 18 quarters.
  • Tower Research Capital (TRC)'s DermTech, Inc. Common Stock position peaked at $217K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.